CompletedNCT00667745
Lithium added to optimized care for bipolarity
About this title
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Read the official source — NCT00667745Medication studyAges 18–80United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- Stanford and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 283
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT00667745
- Official title
Show the full official title
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford · Boston · Cleveland
3 more locations
- Philadelphia
- Pittsburgh
- San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Lithium Carbonate and Optimized Treatment (OPT).
Who was this study for?
Listed age limits: 18 years to 80 years.
